Bridgepoint Group (LON:BPT) Shares Up 1.6% – Time to Buy?

Shares of Bridgepoint Group plc (LON:BPT) shot up 1.6% on Wednesday . The company traded as high as GBX 276.80 and last traded at GBX 268.55. 944,432 shares traded hands during trading, a decline of 82% from the average session volume of 5,388,044 shares. The stock had previously closed at GBX 264.40.

Wall Street Analysts Forecast Growth

Separately, Citigroup reduced their target price on Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating for the company in a report on Tuesday, April 14th. Two investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 385.

Bridgepoint Group Stock Up 1.1%

The company has a current ratio of 279.03, a quick ratio of 3.60 and a debt-to-equity ratio of 55.04. The firm has a market cap of £2.36 billion, a PE ratio of 55.10, a price-to-earnings-growth ratio of 0.61 and a beta of 1.36. The stock has a fifty day simple moving average of GBX 251.89 and a two-hundred day simple moving average of GBX 265.02.

Bridgepoint Group (LON:BPT) last posted its earnings results on Thursday, March 12th. The company reported GBX 26.50 earnings per share for the quarter. Bridgepoint Group had a return on equity of 4.25% and a net margin of 7.68%. As a group, sell-side analysts expect that Bridgepoint Group plc will post 17.4062165 EPS for the current fiscal year.

Insider Activity at Bridgepoint Group

In other Bridgepoint Group news, insider Michelle Scrimgeour acquired 21,616 shares of the business’s stock in a transaction dated Thursday, March 12th. The stock was bought at an average price of GBX 230 per share, with a total value of £49,716.80. Insiders own 0.60% of the company’s stock.

Bridgepoint Group Company Profile

Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.